The EPS projection of Monsanto Company (NYSE:MON) for quarter ended 2016-08-31 is $-0.02. Last week, the EPS forecast was $-0.02 against target of $-0.02, a month earlier. Two months ago, this estimate was $-0.02 versus forecast of $-0.02 three months earlier, implying a deviation of 0%.
Monsanto Company (NYSE:MON) stated that 18 days ago, its stock price was positively revised 2 times while negative revisions were 5.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 0, and 0, correspondingly.
EPS estimate downgrade for Monsanto Company (NYSE:MON) in the preceding 30, 120, 60 and 90 days were 0, 6, 0, and 5, correspondingly.
Monsanto Company (NYSE:MON) EPS target for the quarter closed 2 was $-0.02, based on 10 recommendations. As reported on 2016-04-06 the EPS was $2.42. The change was $-0.03, implying a percentage deviation of -1.22%. The projections showed a standard deviation of 0.12.
Quarterly Sales Estimates
Monsanto Company (NYSE:MON) yearly sales prediction for the fiscal 2016 stands at $2463.032 and the median estimate is at $2459. Almost 4 analysts issued sales target.
Highest sales target is $2592.63 while the lowest target is $2341.5 showing standard deviation of 102.953%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 1.348%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Monsanto Company (NYSE:MON) announced that the deviation in forecast was 3.39%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...